Wang D - Search Results

1

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Zhang Y, Wang D, Johnson AD, Papp AC, Sadée W. Zhang Y, et al. Among authors: wang d. J Biol Chem. 2005 Sep 23;280(38):32618-24. doi: 10.1074/jbc.M504942200. Epub 2005 Jul 26. J Biol Chem. 2005. PMID: 16046395 Free article.

2

Differential effects of mu-opioid receptor ligands on Ca(2+) signaling.

Quillan JM, Carlson KW, Song C, Wang D, Sadée W. Quillan JM, et al. Among authors: wang d. J Pharmacol Exp Ther. 2002 Sep;302(3):1002-12. doi: 10.1124/jpet.302.3.1002. J Pharmacol Exp Ther. 2002. PMID: 12183657

3

Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2.

Lin K, Wang D, Sadée W. Lin K, et al. Among authors: wang d. J Biol Chem. 2002 Oct 25;277(43):40789-98. doi: 10.1074/jbc.M202745200. Epub 2002 Aug 27. J Biol Chem. 2002. PMID: 12200418 Free article.

4

Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.

Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadée W. Wang D, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):512-20. doi: 10.1124/jpet.103.054049. Epub 2003 Nov 4. J Pharmacol Exp Ther. 2004. PMID: 14600246

5

Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.

Sadée W, Wang D, Bilsky EJ. Sadée W, et al. Among authors: wang d. Life Sci. 2005 Feb 11;76(13):1427-37. doi: 10.1016/j.lfs.2004.10.024. Epub 2004 Dec 8. Life Sci. 2005. PMID: 15680308 Review.

6

In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.

Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadée W, Bilsky EJ. Raehal KM, et al. Among authors: wang d. J Pharmacol Exp Ther. 2005 Jun;313(3):1150-62. doi: 10.1124/jpet.104.082966. Epub 2005 Feb 16. J Pharmacol Exp Ther. 2005. PMID: 15716384

7

Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer.

Wang D, Sun X, Bohn LM, Sadée W. Wang D, et al. Mol Pharmacol. 2005 Jun;67(6):2173-84. doi: 10.1124/mol.104.010272. Epub 2005 Mar 18. Mol Pharmacol. 2005. PMID: 15778451

8

Polymorphisms affecting gene regulation and mRNA processing: broad implications for pharmacogenetics.

Johnson AD, Wang D, Sadee W. Johnson AD, et al. Among authors: wang d. Pharmacol Ther. 2005 Apr;106(1):19-38. doi: 10.1016/j.pharmthera.2004.11.001. Epub 2004 Dec 15. Pharmacol Ther. 2005. PMID: 15781120 Review.

9

Calmodulin interaction with peptides from G-protein coupled receptors measured with S-Tag labeling.

Zhang Y, Wang D, Sadée W. Zhang Y, et al. Among authors: wang d. Biochem Biophys Res Commun. 2005 Jul 29;333(2):390-5. doi: 10.1016/j.bbrc.2005.05.129. Biochem Biophys Res Commun. 2005. PMID: 15950946

10

Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability.

Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. Wang D, et al. Pharmacogenet Genomics. 2005 Oct;15(10):693-704. Pharmacogenet Genomics. 2005. PMID: 16141795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,874 results

Search Page

Filters